Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Moolec Science's Enterprise Value is $76.9 Mil.
Moolec Science's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-111.8 Mil. Therefore, Moolec Science's EV-to-EBIT ratio for today is -0.69.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Moolec Science's Enterprise Value is $76.9 Mil.
Moolec Science's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-88.4 Mil. Therefore, Moolec Science's EV-to-EBITDA ratio for today is -0.87.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Moolec Science's Enterprise Value is $76.9 Mil.
Moolec Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $338.8 Mil. Therefore, Moolec Science's EV-to-Revenue ratio for today is 0.23.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Moolec Science's Enterprise Value is $76.9 Mil.
Moolec Science's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $4.4 Mil. Therefore, Moolec Science's EV-to-FCF ratio for today is 17.62.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Moolec Science (NAS:MLEC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Moolec Science's current Enterprise Value is $76.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-111.8 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Moolec Science's current Enterprise Value is $76.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-88.4 Mil.
Moolec Science's current Enterprise Value is $76.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $338.8 Mil.
Moolec Science's current Enterprise Value is $76.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $5.9 Mil.
Moolec Science's current Enterprise Value is $76.9 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Moolec Science's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $4.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moolec Science Enterprise Value Related Terms
Moolec Science Enterprise Value Historical Data
* Premium members only.
The historical data trend for Moolec Science's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLEC vs RVPH, CDIO, DRMA: Enterprise Value Comparison
For the Biotechnology subindustry, Moolec Science's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Moolec Science's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Moolec Science's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Moolec Science (MLEC) has a Enterprise Value of $76.9 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Moolec Science and its competitors.
Is Moolec Science's Enterprise Value too high?
Moolec Science's current Enterprise Value is $76.9 Mil. Overall, Moolec Science has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Enterprise Value compare to RVPH and CDIO?
Moolec Science's Enterprise Value of $76.9 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Moolec Science and its competitors. Moolec Science's current Enterprise Value is $76.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $7.62 — trading 91% below its estimated fair value. The current Enterprise Value is $76.9 Mil. Moolec Science's overall GF Score™ is 46/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Moolec Science (MLEC), the current Enterprise Value is $76.9 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $7.62 is trading 91% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
Enterprise Value: $76.9 Mil
GF Value™: $84.84 vs. price of $7.62 (91% below fair value)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
46GF Score
Get the complete analysis for MLEC
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
